menu-hamburger-svgrepo-com

WEBINAR REPLAY

Anxiety disorders and recommended treatments: Insights from Dr Christian Schüler

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Presented by

:
:
DAYS
HRS
MINS

BOOKINGS

An illustrated diagram of a brain indicating areas associated with stress and anxiety responses.

In the vast field of mental health, anxiety disorders pose significant challenges affecting millions of individuals. This article considers these disorders, their potential treatments, and recent research findings.

If you missed the CPD-accredited webinar on Anxiety and it’s treatment​, click the link below to access the content. You will still earn a CEU from watching the replay. This webinar was sponsored by Adcock Ingram. Click here to watch the replay.

In the realm of mental health, anxiety disorders stand as some of the most prevalent and impactful conditions affecting millions worldwide.

Anxiety is a natural response to stress, often serving as a beneficial mechanism to alert us to potential dangers and help us focus. However, when anxiety becomes excessive and uncontrollable, it can morph into an anxiety disorder. These disorders, which encompass conditions like generalised anxiety disorder (GAD), panic disorder, phobias, and more, affect nearly 30% of adults at some point in their lives. Dr Schüler emphasises that anxiety disorders manifest in various forms, each with its own set of symptoms and challenges. For instance, GAD is characterised by persistent and excessive worry that interferes with daily activities, while panic disorder involves recurrent panic attacks accompanied by overwhelming physical and psychological distress.

Phobias, including specific phobias and agoraphobia, entail irrational fears of specific objects, situations, or environments, often leading individuals to extreme measures to avoid them. Social anxiety disorder, on the other hand, involves intense anxiety and discomfort in social interactions, hindering daily functioning and lasting for extended periods.

Separation anxiety disorder and selective mutism are unique conditions, particularly affecting children, with symptoms revolving around excessive fear or avoidance of separation from loved ones and difficulty speaking in certain social situations, respectively. Posttraumatic stress disorder (PTSD), another anxiety-related disorder, stems from exposure to traumatic events and is characterised by intrusive thoughts, avoidance behaviours, and alterations in cognition and mood. Obsessive-compulsive disorder (OCD), marked by recurrent obsessions and compulsions, further adds to the complexity of anxiety disorders.

Understanding the risk factors contributing to anxiety disorders is crucial for effective management and treatment. Genetic predispositions, neurobiological factors, environmental stressors, and personality traits all play significant roles. Additionally, childhood experiences, such as trauma or adversity, can heighten vulnerability to these conditions later in life.

The impact of anxiety disorders extends beyond individual suffering, affecting various aspects of life, including quality of life, social interactions, occupational performance, and physical health. Recognising these consequences underscores the importance of early intervention and comprehensive treatment approaches.

Anxiety disorders, despite their prevalence, often remain unaddressed as many individuals may not recognise their symptoms as a treatable condition. Driven by various factors, including genetic predispositions, neurobiological alterations, and environmental stressors, anxiety disorders require comprehensive diagnostic and therapeutic strategies for effective management. Exploring the diverse array of treatment options sheds light on how individuals grappling with anxiety can find relief and regain control over their lives.

While anxiety disorders pose significant challenges, they are treatable with a combination of psychotherapeutic and pharmacotherapy interventions.

Diagnosis and treatment

One of the primary challenges in addressing anxiety disorders is the failure of many affected individuals to seek help. Often, individuals may not recognise their symptoms as indicative of a diagnosable condition, leading to delays in seeking appropriate care. It is crucial to first exclude any physical causes for the symptoms before proceeding with treatment. However, once diagnosed, anxiety disorders typically respond well to two main types of treatment: psychotherapy and pharmacotherapy. These treatments can be utilised independently or in combination to tailor the approach to each individual's needs.

Therapies

Psychotherapy: Psychotherapy encompasses a variety of approaches aimed at addressing the cognitive and behavioural aspects of anxiety disorders. Techniques such as cognitive-behavioural therapy (CBT), dialectical behaviour therapy (DBT), psychodynamic psychotherapy, and rapid trauma therapy offer valuable tools for challenging maladaptive thought patterns, regulating emotions, and addressing unresolved conflicts contributing to anxiety.

Psychedelic-assisted therapy: While still in its nascent stages, psychedelic-assisted therapy, particularly involving substances like Ketamine, shows promise in treating anxiety-related conditions. However, it requires careful consideration, thorough psychiatric assessment, and medical supervision due to its potent nature and potential risks. Pharmacotherapy: Medications play a significant role in managing anxiety symptoms, although they do not offer a cure. Antidepressants, such as SSRIs and SNRIs, are commonly prescribed to modulate neurotransmitter levels and alleviate anxiety. Additionally, anxiolytic medications like benzodiazepines and beta-blockers may be used for short-term relief of acute symptoms. However, careful monitoring and adherence to treatment guidelines are essential to minimise risks and optimise outcomes.

Understanding neurotransmitters

Neurotransmitters, the chemical messengers of the brain, play a crucial role in anxiety regulation. Excitatory neurotransmitters, such as glutamate, augment nerve impulses, while inhibitory neurotransmitters, like GABA, prevent or reduce impulse transmission, thus modulating anxiety levels.

Clobazam: A benzodiazepine alternative

Clobazam stands out among benzodiazepines due to its unique structural composition and partial agonist activity. With reduced sedative effects compared to other benzodiazepines, clobazam offers a valuable option for managing anxiety, particularly in crisis situations. Its rapid onset of action, linear kinetics, and favourable safety profile make it an effective choice for acute symptom relief.

Key messages

Clobazam presents a viable alternative in the management of anxiety disorders, offering rapid relief with minimised sedative effects. Its distinct pharmacological properties and safety profile make it a valuable addition to the treatment armamentarium, particularly in crisis management scenarios. By understanding the diverse array of treatment options available, individuals grappling with anxiety can navigate their journey towards healing and reclaiming their lives from the grips of anxiety disorders.

Dr Schüler's expertise sheds light on the complexities of anxiety disorders and underscores the importance of tailored treatment plans to help individuals lead fulfilling lives despite their struggles.

Sign in to access full articles and earn your CPD points.

Clinical and CPD content is compiled by Key Opinion Leaders and our expert medical editors.

Already registered? Login here

Past webinars

Suggested clinical & CPD content

Related articles

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Please check your email for an activation mail. Click the activation link to activate your account

Stay up to date

Search for anything across CPD, webinars and journals
idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! You have successfully booked your seat.

All webinar details will be emailed to your email address.

Did you know, you can book future webinars with a single click if you register an account with Medical Academic.

Congratulations! Your account was successfully created.

Your webinar seat has been booked and all webinar details will be emailed to your registered email address

Why not register for Medical Academic while booking your seat for this webinar?

Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.

Book webinar & create your account

* (Required)

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Thank you for registering. You can now log in to your account.

Create your account

* (Required)

Login with One Time Pin (OTP)

Enter your registered email address to receive an OTP

A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.

We've sent your OTP
Welcome to Medical Academic​

Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.